Common use of Conversion of Advances Clause in Contracts

Conversion of Advances. The Company hereby agrees that Newco shall issue to Purchaser an aggregate of ninety one thousand one hundred and six (91,106) shares (the “Shares”) of Common Stock of Newco, and the Purchaser hereby agrees to convert the Advances into the Shares. The number of Shares has been determined based upon dividing the outstanding Advances by 5.4881. The Company agrees that Newco will instruct its transfer agent to issue the Shares to Purchaser promptly upon closing of the Public Offering. It is understood that any accrued interest on the Advances shall be extinguished as soon as the Advances will be converted to Shares at the closing of the Public Offering. The conversion of the Advances shall occur concurrently with the closing of the Public Offering and is conditioned thereon.

Appears in 2 contracts

Samples: Debt Conversion Agreement (Hemoglobin Oxygen Therapeutics LLC), Debt Conversion Agreement (Hemoglobin Oxygen Therapeutics LLC)

AutoNDA by SimpleDocs

Conversion of Advances. The Company hereby agrees that Newco shall issue to Purchaser an aggregate of ninety one million eight hundred forty four thousand one hundred and six twenty three (91,1061,844,023) shares (the “Shares”) of Common Stock of Newco, and the Purchaser hereby agrees to convert the Advances into the Shares. The number of Shares has been determined based upon dividing the outstanding Advances by 5.48812.744. The Company agrees that Newco will instruct its transfer agent to issue the Shares to Purchaser promptly upon closing of the Public Offering. It is understood that any accrued interest on the Advances shall be extinguished as soon as the Advances will be converted to Shares at the closing of the Public Offering. The conversion of the Advances shall occur concurrently with the closing of the Public Offering and is conditioned thereon.

Appears in 1 contract

Samples: Debt Conversion Agreement (Hemoglobin Oxygen Therapeutics LLC)

Conversion of Advances. The Company hereby agrees that Newco shall issue to Purchaser an aggregate of ninety one eighty two thousand one eight hundred and six twenty five (91,10682,825) shares (the “Shares”) of Common Stock of Newco, and the Purchaser hereby agrees to convert the Advances into the Shares. The number of Shares has been determined based upon dividing the outstanding Advances by 5.48813.6221. The Company agrees that Newco will instruct its transfer agent to issue the Shares to Purchaser promptly upon closing of the Public Offering. It is understood that any accrued interest on the Advances shall be extinguished as soon as the Advances will be converted to Shares at the closing of the Public Offering. The conversion of the Advances shall occur concurrently with the closing of the Public Offering and is conditioned thereon.

Appears in 1 contract

Samples: Debt Conversion Agreement (Hemoglobin Oxygen Therapeutics LLC)

Conversion of Advances. The Company hereby agrees that Newco shall issue to Purchaser an aggregate of ninety one thirty eight thousand one six hundred and six fifty two (91,10638,652) shares (the “Shares”) of Common Stock of Newco, and the Purchaser hereby agrees to convert the Advances into the Shares. The number of Shares has been determined based upon dividing the outstanding Advances by 5.48813.6221. The Company agrees that Newco will instruct its transfer agent to issue the Shares to Purchaser promptly upon closing of the Public Offering. It is understood that any accrued interest on the Advances shall be extinguished as soon as the Advances will be converted to Shares at the closing of the Public Offering. The conversion of the Advances shall occur concurrently with the closing of the Public Offering and is conditioned thereon.

Appears in 1 contract

Samples: Debt Conversion Agreement (Hemoglobin Oxygen Therapeutics LLC)

Conversion of Advances. The Company hereby agrees that Newco shall issue to Purchaser an aggregate of ninety forty one thousand one nine hundred and six nine (91,10641,909) shares (the “Shares”) of Common Stock of Newco, and the Purchaser hereby agrees to convert the Advances into the Shares. The number of Shares has been determined based upon dividing the outstanding Advances by 5.4881. The Company agrees that Newco will instruct its transfer agent to issue the Shares to Purchaser promptly upon closing of the Public Offering. It is understood that any accrued interest on the Advances shall be extinguished as soon as the Advances will be converted to Shares at the closing of the Public Offering. The conversion of the Advances shall occur concurrently with the closing of the Public Offering and is conditioned thereon.

Appears in 1 contract

Samples: Debt Conversion Agreement (Hemoglobin Oxygen Therapeutics LLC)

AutoNDA by SimpleDocs

Conversion of Advances. The Company hereby agrees that Newco shall issue to Purchaser an aggregate of ninety forty one thousand one four hundred and six twelve (91,10641,412) shares (the “Shares”) of Common Stock of Newco, and the Purchaser hereby agrees to convert the Advances into the Shares. The number of Shares has been determined based upon dividing the outstanding Advances by 5.48813.6221. The Company agrees that Newco will instruct its transfer agent to issue the Shares to Purchaser promptly upon closing of the Public Offering. It is understood that any accrued interest on the Advances shall be extinguished as soon as the Advances will be converted to Shares at the closing of the Public Offering. The conversion of the Advances shall occur concurrently with the closing of the Public Offering and is conditioned thereon.

Appears in 1 contract

Samples: Debt Conversion Agreement (Hemoglobin Oxygen Therapeutics LLC)

Conversion of Advances. The Company hereby agrees that Newco shall issue to Purchaser an aggregate of ninety one thirteen thousand one eight hundred and six four (91,10613,804) shares (the “Shares”) of Common Stock of Newco, and the Purchaser hereby agrees to convert the Advances into the Shares. The number of Shares has been determined based upon dividing the outstanding Advances by 5.48813.6221. The Company agrees that Newco will instruct its transfer agent to issue the Shares to Purchaser promptly upon closing of the Public Offering. It is understood that any accrued interest on the Advances shall be extinguished as soon as the Advances will be converted to Shares at the closing of the Public Offering. The conversion of the Advances shall occur concurrently with the closing of the Public Offering and is conditioned thereon.

Appears in 1 contract

Samples: Debt Conversion Agreement (Hemoglobin Oxygen Therapeutics LLC)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!